STARLIMS Announces Shareholder Approval of Acquisition by Abbott
16 2월 2010 - 10:05PM
STARLIMS Technologies Ltd. (Nasdaq:LIMS ), a leading provider of
laboratory information management systems (LIMS), today announced
that at its special meeting of shareholders held today, STARLIMS's
shareholders approved the terms and conditions of the previously
announced acquisition of STARLIMS by Abbott (NYSE:ABT), the global
health care company.
The transaction is subject to customary closing
conditions. Under Israeli law, at least 30 days must have
elapsed after the approval of the acquisition by the shareholders
of STARLIMS before the acquisition may become
effective. STARLIMS and Abbott expect to complete the
transaction by March 31, 2010.
About STARLIMS
STARLIMS Technologies Ltd. (Nasdaq:LIMS) is a leading provider
of laboratory information management systems (LIMS), with over 20
years of LIMS experience. The Company's flagship product,
STARLIMS®, improves the reliability of laboratory sampling
processes, supports compliance with domestic and international
regulations and industry standards, and provides comprehensive
reporting, monitoring and analysis capabilities. STARLIMS software
is used for quality assurance and control, testing and monitoring,
and research and development in government, manufacturing and life
sciences organizations. With operations in the United States,
Canada, the United Kingdom, Israel and Hong Kong, the company
serves over 500 organizations in 40 countries. For more
information, please see http://www.starlims.com.
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. Forward-looking statements involve known and unknown risks
and uncertainties which could cause the actual results, performance
or achievements of the company to be materially different from
those which may be expressed or implied by such statements,
including, among others, changes in general economic and business
conditions, changes in demand for products and services, the timing
and amount or cancellation of orders, loss of market share and
other risks detailed from time to time in STARLIMS's filings from
time to time with the Securities and Exchange Commission. Such
filings contain and identify these and other important factors that
could cause actual results to differ materially from those
contained in our projections or forward-looking statements.
Shareholders and other readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of the date on which they are made. We undertake no obligation to
update publicly or revise any forward-looking statement.
CONTACT: STARLIMS Technologies Ltd.
Tamar Harris, Director of Corporate Communications
(604) 961-6121
tamar.harris@starlims.com
Integrated Corporate Relations (ICR)
Investor Relations:
Kori Doherty
(617) 956-6730
kori.doherty@icrinc.com
Starlims Technologies Ltd. (MM) (NASDAQ:LIMS)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Starlims Technologies Ltd. (MM) (NASDAQ:LIMS)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024